Overview
Hippocratic AI builds AI agents for patient-facing healthcare tasks such as pre-operative calls, follow-up and chronic-care check-ins, limited to non-diagnostic work. On 3 November 2025 it announced a US$126 million Series C at a US$3.5 billion valuation, led by Avenir Growth[54]. That followed a US$141 million Series B led by Kleiner Perkins at a US$1.64 billion valuation on 9 January 2025, and a US$17 million investment from NVIDIA’s NVentures in September 2024[54]. Its investors therefore include both NVIDIA’s venture arm and the two firms that led successive rounds, Kleiner Perkins and Avenir Growth. The company has not disclosed revenue. Clinical-safety validation and health-system procurement cycles slow its deployments.
Appears in
Hippocratic AI alternatives and competitors
Alternatives to Hippocratic AI: companies ranked in the same lists.
- NVIDIA
Crusoe
Pony AI
WhiteFiber- MiniMax
- Recursion Pharmaceuticals
Rezolve AI
Nscale
Kodiak AI
Aurora Innovation
Figure AI
Scale AI
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.